7 results
Search Results
Now showing 1 - 7 of 7
Item Metadata only Demographic and socioeconomic obstacles to access to malaria services for Myanmar migrants in Thailand(2024-12-01) Sripoorote P.; Wattanagoon Y.; Inthitanon N.; Petchvijit P.; Thongyod W.; Win K.M.; Anantjitsupha A.; Min N.B.B.; Rachaphaew N.; Suk-aum K.; Watakulsin P.; Sattabongkot J.; Nguitragool W.; Aung P.L.; Sripoorote P.; Mahidol Universitydisplacement. This study aimed to investigate the demographic and socioeconomic obstacles to access to malaria services among Myanmar migrants residing in the Thailand–Myanmar border areas. Methods: A cross-sectional study was conducted in early 2024 acrossItem Metadata only The challenges of Plasmodium vivax human malaria infection models for vaccine development(2023-01-05) Roobsoong W.; Yadava A.; Draper S.J.; Minassian A.M.; Sattabongkot J.; Mahidol Universityscientific, logistical, and ethical obstacles, are common to P. vivax research conducted in both non-endemic and endemic countries, with additional hurdles unique to each. The challenges of using CHMI for P. vivax vaccine development and evaluation, lessonsItem Metadata only Enhancing Primaquine Adherence for Plasmodium vivax Malaria: A Cluster-Randomized Controlled Trial in Myanmar(2025-07-01) Win K.M.; Aung P.L.; Linn N.Y.Y.; Ring Z.; Kyaw M.P.; Nguitragool W.; Cui L.; Sattabongkot J.; Lawpoolsri S.; Win K.M.; Mahidol UniversityThe rising prevalence of Plasmodium vivax (P. vivax) malaria challenges elimination efforts, particularly in the Greater Mekong Subregion, although adherence to the required 14-day primaquine (PQ) regimen remains a major obstacle. This studyItem Metadata only Plasmodium vivax latent liver infection is characterized by persistent hypnozoites, hypnozoite-derived schizonts, and time-dependent efficacy of primaquine(2022-09-08) Flannery E.L.; Kangwanrangsan N.; Chuenchob V.; Roobsoong W.; Fishbaugher M.; Zhou K.; Billman Z.P.; Martinson T.; Olsen T.M.; Schäfer C.; Campo B.; Murphy S.C.; Mikolajczak S.A.; Kappe S.H.I.; Sattabongkot J.; Mahidol University. These asymptomatic and undetectable latent liver infections present a significant obstacle to the goal of global malaria eradication. We use a human liver-chimeric mouse model (FRG huHep) to study P. vivax hypnozoite latency and activation in an in vivo model systemItem Metadata only Malaria control among Myanmar migrants in Thailand: a qualitative study of healthcare providers(2025-12-01) Inthitanon N.; Sripoorote P.; Wattanagoon Y.; Petchvijit P.; Anantjitsupha A.; Win K.M.; Rachaphaew N.; Htwe K.Z.Z.; Suk-aum K.; Watakulsin P.; Cui L.; Sattabongkot J.; Parker D.M.; Nguitragool W.; Aung P.L.; Inthitanon N.; Mahidol Universityamong these high-risk populations, presents significant challenges. This study aimed to identify key obstacles and propose targeted solutions for enhancing malaria control among Myanmar migrants in border areas of Thailand. Methods: A cross-sectionalItem Metadata only Mass Spectrometry Identification of Biomarkers in Extracellular Vesicles from Plasmodium vivax Liver Hypnozoite Infections(2022-10-01) Gualdrón-López M.; Díaz-Varela M.; Zanghi G.; Aparici-Herraiz I.; Steel R.W.J.; Schäfer C.; Cuscó P.; Chuenchob V.; Kangwangransan N.; Billman Z.P.; Olsen T.M.; González J.R.; Roobsoong W.; Sattabongkot J.; Murphy S.C.; Mikolajczak S.A.; Borràs E.; Sabidó E.; Fernandez-Becerra C.; Flannery E.L.; Kappe S.H.I.; del Portillo H.A.; Mahidol UniversityLatent liver stages termed hypnozoites cause relapsing Plasmodium vivax malaria infection and represent a major obstacle in the goal of malaria elimination. Hypnozoites are clinically undetectable, and presently, there are no biomarkersItem Metadata only Assessing the effect of parasite antigen genetic diversity on performance of Plasmodium vivax serological exposure markers for malaria: a multicentre observational diagnostic accuracy study(2026-01-01) Bareng A.P.N.; Wu K.W.; Takashima E.; Argyropoulos D.C.; Smith L.; Naung M.T.; Mazhari R.; Schoffer K.; Kiernan-Walker N.; Abraham A.; Lamont M.; Mehra S.; Lim P.S.; Sattabongkot J.; Monteiro W.; Lacerda M.; Healer J.; Chitnis C.E.; Tham W.H.; Tsuboi T.; Mueller I.; Barry A.E.; Longley R.J.; Bareng A.P.N.; Mahidol UniversityBackground Plasmodium vivax poses a major obstacle to malaria elimination because this parasite can lie dormant in the liver for weeks to months before reactivating and causing a relapse of infection. These dormant forms (hypnozoites) cannot